(S (NP (NP (DT The) (NN outbreak)) (PP (IN of) (NP (DT the) (NNP COVID-19) (NN pandemic)))) (VP (VBZ has) (VP (VBN been) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (NN bulk)) (PP (IN of) (NP (NP (JJ scientific) (NN research)) (CC and) (NP (JJ related) (NNP Twitter) (NNS discussions))))))))) (. .))
(S (S (VP (TO To) (VP (VB unravel) (NP (NP (DT the) (JJ public) (NNS concerns)) (PP (IN about) (NP (DT the) (NNP COVID-19) (NN crisis))) (VP (VBD reflected) (PP (IN in) (NP (DT the) (JJ science-based) (NNP Twitter) (NNS conversations)))))))) (, ,) (NP (DT this) (NN study)) (VP (VBD tracked) (NP (NP (DT the) (NNP Twitter) (NN attention)) (PP (IN around) (NP (DT the) (NNP COVID-19) (NN research) (NNS efforts)))) (PP (IN during) (NP (NP (DT the) (JJ first) (CD three) (NNS months)) (PP (IN of) (NP (CD 2020)))))) (. .))
(S (PP (IN On) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (QP (RB nearly) (CD 1.4) (CD million)) (NNP Twitter) (NNS mentions)) (PP (IN of) (NP (CD 6,162) (JJ COVID-19-related) (JJ scientific) (NNS publications))))))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (JJ temporal) (NN tweeting) (NN dynamic)) (CC and) (NP (NP (DT the) (NNP Twitter) (NNS users)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ online) (NNS discussions)) (PP (IN around) (NP (NNP COVID-19-related) (NN research))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN quantity)) (PP (IN of) (NP (NP (NNP Twitter) (NNS mentions)) (PP (IN of) (NP (JJ COVID-19-related) (NNS publications)))))) (VP (VBD was) (PP (IN on) (S (VP (NN rising)))))))) (. .))
(S (NP (JJ Scholarly-oriented) (NNP Twitter) (NNS users)) (VP (VBD played) (NP (DT an) (JJ influential) (NN role)) (PP (IN in) (S (VP (VBG disseminating) (NP (NP (NN research) (NNS outputs)) (PP (IN on) (NP (NNP COVID-19))))))) (, ,) (PP (IN with) (S (NP (PRP$ their) (NNS tweets)) (VP (VBG being) (ADVP (RB frequently)) (VP (VBN retweeted)))))) (. .))
(S (PP (IN Over) (NP (NN time))) (, ,) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (DT the) (NN focus)) (PP (IN of) (NP (DT the) (NNP Twitter) (NNS discussions)))))) (VP (MD can) (VP (VB be) (VP (VBN observed) (, ,) (PP (PP (IN from) (NP (NP (DT the) (JJ initial) (NN attention)) (PP (TO to) (NP (ADJP (JJ virological) (CC and) (JJ clinical)) (NN research))))) (PP (TO to) (NP (NP (NP (ADJP (RBR more) (JJ practical)) (NNS topics)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (JJ potential) (NNS treatments)) (, ,) (NP (NP (DT the) (NNS countermeasures)) (PP (IN by) (NP (DT the) (NNS governments)))) (, ,) (NP (DT the) (NN healthcare) (NNS measures)) (, ,) (CC and) (NP (NP (DT the) (NNS influences)) (PP (IN on) (NP (DT the) (NN economy) (CC and) (NN society))))))) (, ,) (PP (IN in) (NP (ADJP (RBR more) (JJ recent)) (NNS times))))))))) (. .))
